A Randomized Controlled Trial of Metacognitive Therapy and EMDR for Posttraumatic Stress Disorder
Launched by NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY · Sep 27, 2013
Trial Information
Current as of August 02, 2025
Completed
Keywords
ClinConnect Summary
EMDR is based on the assumption that posttraumatic symptoms are due to the traumatic experience(s) being stored in an unprocessed way disconnected from existing memory networks. The procedure in EMDR is postulated to facilitate the processing of the traumatic memory into existing memory networks. There is currently no empirical knowledge as to the therapeutic mechanisms of EMDR, but the protocol overlaps with core components of cognitive behavior therapy (CBT), such as imaginal exposure and cognitive restructuring of negative trauma-related cognitions. Thus, EMDR could be viewed as a form o...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • a primary diagnosis of PTSD according to the Anxiety Disorders Interview Schedule (ADIS-IV)
- • not previously received EMDR or MCT for this diagnosis
- • not actively suicidal, presenting with suicidal ideation, psychotic or suffering from severe depression
- • no evidence of alcohol or drug dependence
- • Symptom chronicity of \>3 months post-trauma
- Exclusion Criteria:
- • PTSD is not the primary diagnosis
- • expressing suicidal ideation, actively psychotic, or engaging in overt self-harm
- • Evidence of alcohol or drug dependence requiring treatment in its own right
- • Borderline personality disorder
- • Symptom chronicity \<3 months post-trauma
- • no ability to understand or speak Norwegian
About Norwegian University Of Science And Technology
The Norwegian University of Science and Technology (NTNU) is a leading research institution dedicated to advancing knowledge and innovation in various scientific fields. Renowned for its commitment to interdisciplinary collaboration, NTNU plays a pivotal role in addressing global health challenges through rigorous clinical trials and research initiatives. The university's emphasis on cutting-edge technology and its strong partnerships with healthcare sectors position it as a key player in translational research, ensuring that findings contribute effectively to improving public health and patient care. With a focus on ethical standards and scientific integrity, NTNU is dedicated to fostering advancements that enhance the quality of life and health outcomes for diverse populations.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Trondheim, , Norway
Patients applied
Trial Officials
Hans M Nordahl, Prof
Study Director
Department of Psychology, Norwegian University of Science and Technology
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials